Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study. | Int J Gen Med;15: 5915-5918, 2022. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study.

Hao, Zhengyang; Zhang, Yanzhou.

Affiliation

Hao Z; Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.
Zhang Y; Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.

Int J Gen Med ; 15: 5915-5918, 2022.

Article in En | MEDLINE | ID: mdl-35800000

Key words

dapagliflozin; empagliflozin; heart failure with reduced ejection fraction

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Int J Gen Med Year: 2022 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Int J Gen Med Year: 2022 Type: Article